francesco paolo perelli

[European Society of Cardiology Journals @ESC_Journals]

Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences. Discover more in #EHJ
👉 https://t.co/DtPW4iQRFT

@RoccoMontone @ehj_ed

[JACC Journals @JACCJournals]

Dantrolene shows promise as a safe, feasible strategy to prevent doxorubicin-induced #cardiomyopathy (DIC). Already used for malignant #hyperthermia, it may be repurposed for DIC prevention. https://t.co/iVPql9iaxS

#JACCCardioOnc #cvPrev #CardioOnc

[European Society of Cardiology Journals @ESC_Journals]

How does flecainide induce ventricular tachycardia & how can it be managed? https://t.co/4htLoRLWWt

#EHJCaseReports @Phiso_de @TJ_Yeo @aayshacader @BoldiKovacsMD @SukritiBanthiya @ANazmiCalik @O_Azizy_MD @saramoscatelli7 @EHJCREiC #CardioX #EPeeps

[francesco paolo perelli @fpperelli]

Association of GLP-1 Receptor Agonists Versus Bariatric Surgery with Outcomes in Obese Patients with Hypertrophic Cardiomyopathy: A Multicenter Propensity-Matched Analysis https://t.co/NytA33A5z0

[francesco paolo perelli @fpperelli]

Low Burden Transthyretin Cardiac Amyloidosis on Cardiac Magnetic Resonance: Comprehensive Phenotyping and Distinction from Hypertrophic Phenocopies https://t.co/d5alpkiaJO

[European Society of Cardiology Journals @ESC_Journals]

Coronary microvascular dysfunction as an initial clue to the diagnosis of light-chain amyloidosis https://t.co/iNwRrNjn0e

#EHJCaseReports @Phiso_de @TJ_Yeo @aayshacader @BoldiKovacsMD @SukritiBanthiya @ANazmiCalik @O_Azizy_MD @saramoscatelli7 @EHJCREiC #CardioX

[Journal of CMR @journalofCMR]

❤️ 🧲CMR T2 mapping predicts survival in AL amyloidosis—even after strong treatment response. Myocardial edema flags hidden risk beyond biomarkers.

pdf 👉 https://t.co/PT10Tg7DUx

Dr. Yining Wang explains below 👇
#WhyCMR

[JACC Journals @JACCJournals]

The authors present the largest series of #TTVR after T-TEER with electrosurgical leaflet modification in a subset of patients. At 30 days, TR severity was markedly reduced, and substantial symptom alleviation occurred. https://t.co/BInuKZVG1T

#JACCINT #vhdTR #TEER @jtsaxon

[francesco paolo perelli @fpperelli]

Left Ventricular Ejection Fraction and Myocardial Fibrosis in Sudden Cardiac Death https://t.co/4Z9vhXr0N8

[francesco paolo perelli @fpperelli]

Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting https://t.co/lYCqs979hJ

[francesco paolo perelli @fpperelli]

Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysis https://t.co/1NylLwTWfk

[JACC Journals @JACCJournals]

New in #JACCINT: 1-year results from the #CLASPIID trial show #MTEER benefits patients with degenerative MR across all cardiac damage stages 💪 Significant MR & #QoL improvements 🌟 low adverse events ⚡ and low mortality https://t.co/Rnkn21W9AP

#vhdMR #TEER @AbdullahAlabcha

[Zille Huma @Zill_cardio]

2025 ACC Expert Consensus Decision Pathway on Evaluation & Management of Tricuspid Regurgitation

@JACCJournals @ACCinTouch #TR #CardioX

https://t.co/9xd9XVa1fR

[European Society of Cardiology Journals @ESC_Journals]

Atrial fibrillation ablation in hypertrophic obstructive cardiomyopathy – should we propose these patients to intervention? More on the potential outcomes in https://t.co/y3rv984Giy
#EHJQCCO #AFib #HCM #PVI
@cpgale3 @diogoasantosfer @m_piepoli

[francesco paolo perelli @fpperelli]

Today, I had the pleasure of discussing atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac amyloidosis. I would like to thank my mentor for this opportunity and for his continued support. @CrottiLia

[francesco paolo perelli @fpperelli]

Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance https://t.co/GineCMxmhr

[Henry Han @HanCardiomd]

Mitochondrial cardiomyopathies

This review discusses comprehensive overview of the pathophysiology, clinical features, diagnostic approaches, and treatment options for mitochondrial #CMP

https://t.co/cP2oyRWGcZ
#CardioEd @ehj_ed @ESC_Journals

[Denisa Muraru @denisamuraru]

After 3 years of relentless hard work, passion, and dedication to #cvimaging and research in TR, our brilliant PhD student @michetomaselli has successfully defended his thesis!

Michele, your fantastic journey has been inspiring for so many fellows and researchers that had the chance to work with you. The future is bright, and I’m honored to have been part of your path and to work with you daily.

Congratulations—this is just the beginning!

@lpbadano @ClementA25 @giorgio_oliver @Fraheilbron @Springhetti_P @fpperelli @GParati22 @TwittAuxologico @unimib #3DEcho #PhDSuccess #TricuspidRegurgitation #ProudMentor #FutureLeader

[European Society of Cardiology Journals @ESC_Journals]

Therapeutic left-to-right shunting in heart failure. A State-of-the-Art review just published in #EHJ 👉
https://t.co/M7mCTu89h4

@RoccoMontone @ehj_ed #heartfailure

[Enrico Ammirati @AmmiratiEnrico]

NEW ⚡️ Acute myocarditis: 2024 state of the art https://t.co/pF7hDcnZk5